ARGININE-206 OF THE C5A RECEPTOR IS CRITICAL FOR LIGAND RECOGNITION AND RECEPTOR ACTIVATION BY C-TERMINAL HEXAPEPTIDE ANALOGS

被引:56
作者
DEMARTINO, JA
KONTEATIS, ZD
SICILIANO, SJ
VANRIPER, G
UNDERWOOD, DJ
FISCHER, PA
SPRINGER, MS
机构
[1] MERCK & CO INC,RES LABS,DEPT IMMUNOL RES,RAHWAY,NJ 07065
[2] MERCK & CO INC,RES LABS,DEPT BIOCHEM & MOLEC PATHOL,RAHWAY,NJ 07065
[3] MERCK & CO INC,RES LABS,DEPT ANALYT BIOCHEM,RAHWAY,NJ 07065
[4] MERCK & CO INC,RES LABS,DEPT MOLEC SYST,RAHWAY,NJ 07065
[5] UNIV MED & DENT NEW JERSEY,ROBERT WOOD JOHNSON MED SCH,DEPT MOLEC GENET & MICROBIOL,PISCATAWAY,NJ 08854
关键词
D O I
10.1074/jbc.270.27.15966
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
C5a is a 74-amino-acid glycoprotein whose receptor is a member of the rhodopsin superfamily, While antagonists have been generated to many of these receptors, similar efforts directed at family members whose natural ligands are proteins have met with little success, The recent development of hexapeptide analogs of C5a has allowed us to begin elucidation of the molecular events that lead to activation by combining a structure/activity study of the ligand with receptor mutagenesis, Removal of the hexapeptide's C-terminal arginine reduces affinity by 100-fold and eliminates the ability of the ligand to activate the receptor, Both the guanidino side chain and the free carboxyl of the arginine participate in the interaction. The guanidino group makes the energy-yielding contact with the receptor, while the free carboxylate negates ''electrostatic'' interference with Arg-206 of the receptor, It is the apparent movement Arg-206 induced by this set of interactions that is responsible for activation, since conversion of Arg-206 to alanine eliminates the agonist activity of the hexapeptides. Surprisingly, activation is a nearly energy-neutral event and may reflect the binding process rather than the final resting site of the ligand.
引用
收藏
页码:15966 / 15969
页数:4
相关论文
共 26 条
[1]
SURPRISINGLY HIGH-LEVELS OF ANAPHYLATOXIN C5A DES ARG ARE EXTRACTABLE FROM PSORIATIC SCALES [J].
BERGH, K ;
IVERSEN, OJ ;
LYSVAND, H .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 1993, 285 (03) :131-134
[2]
EXPRESSION CLONING OF A RECEPTOR FOR C5A ANAPHYLATOXIN ON DIFFERENTIATED HL-60 CELLS [J].
BOULAY, F ;
MERY, L ;
TARDIF, M ;
BROUCHON, L ;
VIGNAIS, P .
BIOCHEMISTRY, 1991, 30 (12) :2993-2999
[3]
DEMARTINO JA, 1994, J BIOL CHEM, V269, P14446
[4]
SYNTHETIC C5A-RECEPTOR AGONISTS - PHARMACOLOGY, METABOLISM AND INVIVO CARDIOVASCULAR AND HEMATOLOGIC EFFECTS [J].
DRAPEAU, G ;
BROCHU, S ;
GODIN, D ;
LEVESQUE, L ;
RIOUX, F ;
MARCEAU, F .
BIOCHEMICAL PHARMACOLOGY, 1993, 45 (06) :1289-1299
[5]
EMBER JA, 1992, J IMMUNOL, V148, P3165
[6]
GARDINALI M, 1992, ARCH SURG-CHICAGO, V127, P1219
[7]
THE CHEMOTACTIC RECEPTOR FOR HUMAN-C5A ANAPHYLATOXIN [J].
GERARD, NP ;
GERARD, C .
NATURE, 1991, 349 (6310) :614-617
[8]
GOLDSTEIN IM, 1988, INFLAMMATION BASIC P, P55
[9]
INCREASED LEVELS OF PLASMA ANAPHYLATOXINS IN SYSTEMIC LUPUS-ERYTHEMATOSUS PREDICT FLARES OF THE DISEASE AND MAY ELICIT VASCULAR INJURY IN LUPUS CEREBRITIS [J].
HOPKINS, P ;
BELMONT, HM ;
BUYON, J ;
PHILIPS, M ;
WEISSMANN, G ;
ABRAMSON, SB .
ARTHRITIS AND RHEUMATISM, 1988, 31 (05) :632-641
[10]
HUGLI TE, 1984, SPRINGER SEMIN IMMUN, V7, P193